New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine. The therapeutic …